Noah G. Levy
On April 24, 2025, in connection with the IPO, Daniel J. Hoffman, Dr. Kamal Ghaffarian, William Denkin, and Noah G. Levy were appointed to the board of directors of the Company (the “ Board ”).
Highest-materiality recent filing
Inflection Point shareholders approve business combination with Air Water Ventures
Shareholders approved Business Combination Agreement with Air Water Ventures; 26,212,774 FOR, 729,348 AGAINST.
Inflection Point SPAC receives redemption requests for 24.7M shares ahead of business combination
As of July 27, 2026, Inflection Point received redemption requests for 24,673,661 Class A ordinary shares.
Aggregate base consideration reduced from $300M to $200M.
Inflection Point Acquisition Corp. VI appoints Jae Hyun Park to Board of Directors
Jae Hyun (James) Park appointed as Class II independent director effective April 24, 2026.
Inflection Point III updates Air Water deck; explores additional PIPE financing
Updated investor presentation furnished on Jan 12, 2026 for proposed business combination with Air Water Ventures.
Inflection Point III to merge with Air Water Ventures in $300M SPAC business combination
Entered into Business Combination Agreement with Air Water Ventures Holdings Limited; merger targeted for Q1 2026.
Inflection Point III units may separate into shares and rights from June 16, 2025
Holders can elect to separately trade Class A ordinary shares (IPCX) and rights (IPCXR) starting on or about June 16, 2025.
Inflection Point Acquisition III completes $253M IPO and $7.4M private placement
IPO of 25,300,000 units at $10.00/unit, including full over-allotment of 3,300,000 units, grossing $253,000,000.
Inflection Point Acquisition Corp. III closes $253M SPAC IPO; $253M in trust
Closed IPO of 25,300,000 units at $10.00/unit for gross proceeds of $253,000,000, including full over-allotment exercise.
On April 24, 2025, in connection with the IPO, Daniel J. Hoffman, Dr. Kamal Ghaffarian, William Denkin, and Noah G. Levy were appointed to the board of directors of the Company (the “ Board ”).
On April 24, 2025, in connection with the IPO, Daniel J. Hoffman, Dr. Kamal Ghaffarian, William Denkin, and Noah G. Levy were appointed to the board of directors of the Company (the “ Board ”).
On April 24, 2025, in connection with the IPO, Daniel J. Hoffman, Dr. Kamal Ghaffarian, William Denkin, and Noah G. Levy were appointed to the board of directors of the Company (the “ Board ”).
On April 24, 2025, in connection with the IPO, Daniel J. Hoffman, Dr. Kamal Ghaffarian, William Denkin, and Noah G. Levy were appointed to the board of directors of the Company (the “ Board ”).
Max materiality 0.75 · Median 0.60 · Most common event other_material